Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Survey on the current use of FMT in pediatric patients receiving hematopoietic stem cell transplantation and cellular therapies

Toutes les maladies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Riccardo Masetti

HSCT in patients with GLIS2+ AML study

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Second allogeneic HSCT for relapsed pediatric ALL: a collaborative study on behalf of the Brazilian PDWP (SBTMO) and the European EBMT PDWP (J. Silva, C. Bonfim)

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Julia Silva, Carmen Bonfim

Outcomes of children with AML relapse within 6 months post HSCT (C. Horgan/R. Wynn)

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Claire Horgan / Rob Wynn

Allogeneic vs autologous HSCT in B-cell NHL (D. Przystupski)

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Real-world data on the outcome of HSCT in paediatric patients requiring respiratory support

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Données en vie réelle sur l'issue de la greffe de cellules souches hématopoïétiques chez les patients pédiatriques nécessitant un soutien respiratoire

Toutes les maladies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Outcomes of pediatric patients with acute leukemias who received either post-transplant cyclophosphamide or a haploidentical transplant with TCR αβ/CD19+ lymphocyte depletion

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogeneic - Haploidentical

Investigateur principal

Franco Locatelli

Résultats des patients pédiatriques atteints de leucémies aiguës ayant reçu soit du cyclophosphamide post-transplantation, soit une greffe haplo-identique avec déplétion des lymphocytes TCR αβ/CD19+

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogénique - Haplo-identique

Investigateur principal

Franco Locatelli

Mixed chimerism after related CB HSCT with hemoglobinopathies

Études rétrospectives

Autres anomalies non malignes

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Vanderson Rocha (Brazil)

Comparison of late complications after HCT using Treosulfan based and Busulfan based conditioning regimen for Hemoglobinopathy

Études rétrospectives

Autres anomalies non malignes

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Maura Faraci (Genova)

National Access and need for CAR-T CD19 therapy in Euro region

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Aleksandra Oszer(Lodz)